p53-dependent transcriptional responses to interleukin-3 signaling

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Jabbour, Anissa M ^a,b,c   Gordon, Lavinia ^a   Daunt, Carmel P ^a,b   Green, Benjamin D ^a,b,c   Kok, Chung H ^d   D'Andrea, Richard ^d   Ekert, Paul G ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MARROW CELL; CELL STRESS; CELL VIABILITY; CLONOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; MODULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL SURVIVAL; CYTOLOGY; GENETIC TRANSCRIPTION; GENETICS; METABOLISM;

ANIMALS; CELL SURVIVAL; INTERLEUKIN-3; MAP KINASE SIGNALING SYSTEM; MICE; MYELOID CELLS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84856913593     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031428     Document Type: Article

References (52)

1. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, et al. (2000) Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288: 1053-1058.
2. Han J, Flemington C, Houghton AB, Gu Z, Zambetti GP, et al. (2001) Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals. Proc Natl Acad Sci U S A 98: 11318-11323.
3. Nakano K, Vousden KH, (2001) PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell 7: 683-694.
4. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B, (2001) PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673-682.
5. Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, et al. (2003) Integral role of Noxa in p53-mediated apoptotic response. Genes Dev 17: 2233-2238.
6. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, et al. (2003) p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038.
7. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L, (2003) PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci U S A 100: 1931-1936.
8. Christophorou MA, Ringshausen I, Finch AJ, Swigart LB, Evan GI, (2006) The pathological response to DNA damage does not contribute to p53-mediated tumour suppression. Nature 443: 214-217.
9. Yu J, Zhang L, (2008) PUMA, a potent killer with or without p53. Oncogene 27 (Suppl 1): S71-83.
10. Michalak EM, Vandenberg CJ, Delbridge AR, Wu L, Scott CL, et al. (2010) Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death. Genes Dev 24: 1608-1613.
11. Labi V, Erlacher M, Krumschnabel G, Manzl C, Tzankov A, et al. (2010) Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation. Genes Dev 24: 1602-1607.
12. Jabbour AM, Daunt CP, Green BD, Vogel S, Gordon L, et al. (2010) Myeloid progenitor cells lacking p53 exhibit delayed up-regulation of Puma and prolonged survival after cytokine deprivation. Blood 115: 344-352.
13. Zhao Y, Coloff JL, Ferguson EC, Jacobs SR, Cui K, et al. (2008) Glucose metabolism attenuates p53 and Puma-dependent cell death upon growth factor deprivation. J Biol Chem 283: 36344-36353.
14. Lotem J, Sachs L, (1993) Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82: 1092-1096.
15. Du P, Kibbe WA, Lin SM, (2008) lumi: a pipeline for processing Illumina microarray. Bioinformatics 24: 1547-1548.
16. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
17. Kauffmann A, Gentleman R, Huber W, (2009) arrayQualityMetrics-a bioconductor package for quality assessment of microarray data. Bioinformatics 25: 415-416.
18. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, et al. (2009) A novel signaling pathway impact analysis. Bioinformatics 25: 75-82.
19. Khatri P, Voichita C, Kattan K, Ansari N, Khatri A, et al. (2007) Onto-Tools: new additions and improvements in 2006. Nucleic Acids Res 35: W206-211.
20. Draghici S, Khatri P, Tarca AL, Amin K, Done A, et al. (2007) A systems biology approach for pathway level analysis. Genome Res 17: 1537-1545.
21. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102: 15545-15550.
22. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, et al. (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34: 267-273.
23. Ekert PG, Jabbour AM, Manoharan A, Heraud JE, Yu J, et al. (2006) Cell death provoked by loss of interleukin-3 signaling is independent of Bad, Bim, and PI3 kinase, but depends in part on Puma. Blood 108: 1461-1468.
24. Ekert PG, Read SH, Silke J, Marsden VS, Kaufmann H, et al. (2004) Apaf-1 and caspase-9 accelerate apoptosis, but do not determine whether factor-deprived or drug-treated cells die. J Cell Biol 165: 835-842.
25. Yoshimura A, Nishinakamura H, Matsumura Y, Hanada T, (2005) Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 7: 100-110.
26. Croker BA, Kiu H, Nicholson SE, (2008) SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol 19: 414-422.
27. Amato R, D'Antona L, Porciatti G, Agosti V, Menniti M, et al. (2009) Sgk1 activates MDM2-dependent p53 degradation and affects cell proliferation, survival, and differentiation. J Mol Med 87: 1221-1239.
28. Song L, Xiong H, Li J, Liao W, Wang L, et al. (2011) Sphingosine Kinase-1 Enhances Resistance to Apoptosis through Activation of PI3K/Akt/NF-{kappa}B Pathway in Human Non-Small Cell Lung Cancer. Clin Cancer Res 17: 1839-1849.
29. Marfe G, Di Stefano C, Gambacurta A, Ottone T, Martini V, et al. (2011) Sphingosine kinase 1 overexpression is regulated by signaling through PI3K, AKT2, and mTOR in imatinib-resistant chronic myeloid leukemia cells. Exp Hematol.
30. Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, et al. (2003) Bcl11a is essential for normal lymphoid development. Nat Immunol 4: 525-532.
31. Ferreira BI, Garcia JF, Suela J, Mollejo M, Camacho FI, et al. (2008) Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia. Haematologica 93: 670-679.
32. Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, et al. (2001) The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98: 3413-3420.
33. Agueli C, Cammarata G, Salemi D, Dagnino L, Nicoletti R, et al. (2010) 14q32/miRNA clusters loss of heterozygosity in acute lymphoblastic leukemia is associated with up-regulation of BCL11a. Am J Hematol 85: 575-578.
34. Pfeifer D, Pantic M, Skatulla I, Rawluk J, Kreutz C, et al. (2007) Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays. Blood 109: 1202-1210.
35. Forconi F, Rinaldi A, Kwee I, Sozzi E, Raspadori D, et al. (2008) Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletion. Br J Haematol 143: 532-536.
36. Megan Kong Y, Dahlke C, Xiang Q, Qian Y, Karp D, et al. (2011) Toward an ontology-based framework for clinical research databases. J Biomed Inform 44: 48-58.
37. Messina DN, Glasscock J, Gish W, Lovett M, (2004) An ORFeome-based analysis of human transcription factor genes and the construction of a microarray to interrogate their expression. Genome Res 14: 2041-2047.
38. Moreland RT, Ryan JF, Pan C, Baxevanis AD, (2009) The Homeodomain Resource: a comprehensive collection of sequence, structure, interaction, genomic and functional information on the homeodomain protein family. Database (Oxford) 2009: bap004.
39. Zola H, Swart B, Banham A, Barry S, Beare A, et al. (2007) CD molecules 2006-human cell differentiation molecules. J Immunol Methods 319: 1-5.
40. Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S, (2002) The protein kinase complement of the human genome. Science 298: 1912-1934.
41. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4: 177-183.
42. Endo T, Kusakabe M, Sunadome K, Yamamoto T, Nishida E, (2011) The kinase SGK1 in the endoderm and mesoderm promotes ectodermal survival by down-regulating components of the death-inducing signaling complex. Sci Signal 4: ra2.
43. Yin B, Delwel R, Valk PJ, Wallace MR, Loh ML, et al. (2009) A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood 113: 1075-1085.
44. Khandanpour C, Kosan C, Gaudreau MC, Duhrsen U, Hebert J, et al. (2010) Growth Factor Independence 1 (Gfi1) Protects Hematopoietic Stem Cells Against Apoptosis But Also Prevents the Development of a Myeloproliferative-Like Disease. Stem Cells.
45. Yamamoto T, Ebisuya M, Ashida F, Okamoto K, Yonehara S, et al. (2006) Continuous ERK activation downregulates antiproliferative genes throughout G1 phase to allow cell-cycle progression. Curr Biol 16: 1171-1182.
46. Renneville A, Roumier C, Biggio V, Nibourel O, Boissel N, et al. (2008) Cooperating gene mutations in acute myeloid leukemia: a review of the literature. Leukemia 22: 915-931.
47. Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, et al. (2011) Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 334: 1129-1133.
48. Jeffers JR, Parganas E, Lee Y, Yang C, Wang J, et al. (2003) Puma is an essential mediator of p53-dependent and-independent apoptotic pathways. Cancer Cell 4: 321-328.
49. Letai A, (2006) Growth factor withdrawal and apoptosis: the middle game. Mol Cell 21: 728-730.
50. Mayo LD, Donner DB, (2002) The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network. Trends Biochem Sci 27: 462-467.
51. Kornblau SM, Tibes R, Qiu YH, Chen W, Kantarjian HM, et al. (2009) Functional proteomic profiling of AML predicts response and survival. Blood 113: 154-164.
52. Gudkov AV, Komarova EA, (2010) Pathologies associated with the p53 response. Cold Spring Harb Perspect Biol 2: a001180.